PLATINUM, NCT04443608: Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management |
|
|
| Terminated | 4 | 115 | US | Patiromer Powder for Oral Suspension [Veltassa], Active drug, Placebo, Inactive substance | Comprehensive Research Associates | Hyperkalemia | 03/23 | 06/23 | | |
CHANGE AFIB, NCT05130268: Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation |
|
|
| Completed | 4 | 339 | US | Dronedarone, Multaq | American Heart Association, Duke Clinical Research Institute, Sanofi | Atrial Fibrillation | 01/24 | 06/24 | | |
OASIS, NCT06636786: Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL) |
|
|
| Not yet recruiting | 2 | 180 | US | Cyclobenzaprine HCl, TNX-102 SL, Placebo, Sugar pill | University of North Carolina, Chapel Hill, United States Department of Defense, Tonix Pharmaceuticals, Inc., Mclean Hospital, Cooper University Health Care | Acute Stress Reaction, Acute Stress Disorder, Neurocognitive Function, Post-traumatic Stress | 09/25 | 09/25 | | |
NCT05743283: Efficacy of SynEx Wound Rinse in Civilian Surrogates of Combat Injury Wounds |
|
|
| Recruiting | N/A | 100 | US | SynEx Wound Cleanser, Saline | Synedgen, Inc., United States Department of Defense, Medical Technology Enterprise Consortium | Wound Heal | 09/25 | 09/25 | | |
